Fetal and Neonatal Care Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The fetal and neonatal care equipment market size is expected to grow from USD 9.68 billion in 2025 to USD 10.28 billion in 2026 and is forecast to reach USD 13.91 billion by 2031 at 6.23% CAGR over 2026-2031. This report is Segmented by Product Type (Fetal Care Equipment [Fetal Dopplers and More] and Neonatal Care Equipment [Incubators and More]), End User (Hospitals, Home-Care Settings, and More), Modality (Stand-Alone Devices and Portable/Handheld Devices), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Fetal And Neonatal Care Equipment Market Trends and Insights

Increasing Number of Pre-Term and Low-Birth-Weight Deliveries

Preterm births rose to 10.4% of live births in the United States in 2023, a decade high that translates into sustained demand for advanced incubators, ventilators, and monitoring systems. The March of Dimes estimates annual economic losses of USD 25.2 billion from preterm births, sharpening hospital focus on early-intervention technologies. China’s CARE-Preterm cohort noted a 10.74% mortality rate among very preterm infants, underscoring the clinical need for sophisticated support equipment. Higher maternal age intensifies risk: women aged 40 and older recorded a 14.8% preterm rate, creating a premium segment ready to pay for AI-enabled fetal diagnostics. These factors together lift demand for neonatal devices and recurring consumables that underpin the fetal and neonatal care equipment market.

Accelerating Demand for Point-of-Care Fetal Monitoring in Low-Resource Settings

Affordable innovations are redefining care pathways in emerging economies. A Malawian pilot showed the USD 56 Optoco external tocodynamometer produced clinically acceptable readings compared with premium systems. Uganda’s deployment of the Moyo device improved intrapartum fetal heart-rate detection while maintaining user acceptance. NIH funding that rewards non-invasive prototypes incentivizes commercial scale-up of low-cost monitors nibib.nih.gov. China’s neonatal mortality drop to 2.8 per mille in 2024 further illustrates how public funding lifts demand for accessible equipment. Collectively these trends enlarge the fetal and neonatal care equipment market by opening new buyer segments in low-resource settings.

Stringent Regulatory Timelines for Novel Device Approvals

FDA de-novo approvals fell to only 2 in 2025 versus 12 during 2024 as workforce reductions slowed reviews, adding months to commercialization schedules and deferring revenues. Harmonized Quality System Regulation amendments effective February 2026 introduce new documentation layers that raise compliance costs. Security documentation mandated under Section 524B further extends submission packages. Small innovators, often at the forefront of AI diagnostics, face resource constraints that can delay product launches and temper growth in the fetal and neonatal care equipment market.

Other drivers and restraints analyzed in the detailed report include:

• AI-Powered Predictive Analytics Improving Neonatal Outcomes
• Government Support to Boost NICU Capacity Expansion
• Cyber-Security Risks in Connected Fetal Monitoring Platforms

Segment Analysis

Neonatal equipment controlled 55.61% of 2025 revenue in the fetal and neonatal care equipment market, anchored by incubators, ventilators, and thermoregulation systems sold into expanding NICU footprints. Incubators led unit shipments, with enhancements such as humidity-regulated micro-environments and integrated jaundice forecasting software like Draeger’s BiliPredics elevating clinical value. Respiratory support devices capitalized on rising very-preterm survival rates; Vyaire’s fabian Therapy evolution now offers closed-loop FiO₂ control that reduces manual titration time. The fetal and neonatal care equipment market size for neonatal respiratory devices is projected to climb at 6.97% CAGR through 2031 as guidelines favor early non-invasive ventilation.

Fetal care devices, though smaller in absolute revenue, are on track for an 7.78% CAGR. AI-enhanced ultrasound, exemplified by GE’s Vscan Air CL and Exo’s Iris handheld with SweepAI algorithms, shortens exam times while improving detection fidelity. NIH funding that awarded USD 75,000 to six RADx finalists validates pipeline momentum in non-invasive pulse-oximetry and wearable cardiotocography solutions. The fetal and neonatal care equipment market size for pulse oximeters is forecast to expand 9.08% annually, reflecting demand for continuous, cable-free oxygen-saturation tracking during labor and the early neonatal period.

Complete Report Scope:

• Fetal Dopplers
  • Fetal Magnetic Resonance Imaging (MRI) Devices
    • Ultrasound Devices
    • Fetal Pulse Oximeters
    • Other Fetal Care Equipment
  • Neonatal Care Equipment
    • Incubators
    • Neonatal Monitoring Devices
    • Phototherapy Equipment
    • Respiratory Assistance & Monitoring Devices
    • Other Neonatal Care Equipment
• By End-user
  • Hospitals
  • Maternity Clinics & Birthing Centers
  • Home-Care Settings
• By Modality
  • Stand-alone Devices
  • Portable/Hand-held Devices
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America generated 38.10% of global revenue in 2025 on the back of advanced NICU penetration and early AI adoption. Nevertheless, extended FDA timelines and cybersecurity compliance costs temper near-term growth. The fetal and neonatal care equipment market size in North America is set to rise from USD 3.69 billion in 2025 to USD 5.07 billion by 2031 at a 5.42% CAGR.

Asia Pacific charts a 8.74% CAGR, underpinned by Chinese and Indian public-health investments and aggressive technology scale-up programs. Samsung Medison’s USD 93 million purchase of Sonio signals regional ambition to dominate AI-fetal diagnostics. India’s National Health Mission continues to distribute free neonatal care packages that spur equipment demand in secondary-tier cities.

Europe maintains steady mid-single-digit expansion, helped by sustainability procurement rules that favor helium-free MRI and cableless monitors. Latin America focuses on cost-optimized imports, and the Middle East invests via public-private partnerships to upgrade maternal-fetal services.

List of Companies Covered in this Report:

• Atom Medical Corp.
• Beckton Dickinson
• Dragerwerk
• GE HealthCare Technologies Inc.
• Koninklijke Philips
• Masimo Corp.
• Medtronic
• Natus Medical
• Phoenix Medical Systems
• Vyaire Medical
• Fisher & Paykel Healthcare
• ICU Medical
• Nihon Kohden Corp.
• Inspiration Healthcare Group plc
• Mennen Medical Group
• Fanem LTDA
• Bispectral Medical
• Heinen + Löwenstein GmbH
• Utah Medical Products

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support